Affiliation:
1. Yaroslavl State Medical University, Yaroslavl, Russia
Abstract
Alcohol currently contributes to 5% of the overall global burden of diseases and injuries. Alcohol consumption results in death and disability at young age. Medicinal products approved for treatment of alcohol dependence syndrome include disulfiram, Naltrexone, Cyanamid and nalmefene. Variability of a patient-to-patient pharmacotherapy therapeutic effect can also be associated with genetic causes. Examination of the system of pharmacogenetic markers in narcology will be used to provide for preliminary prognosis of effectiveness and tolerance of medicinal products during personalized anti-relapse (supporting) therapy to support and prolong remission in patients with alcohol dependence.
Publisher
Pirogov Russian National Research Medical University
Subject
General Medicine,General Earth and Planetary Sciences,General Environmental Science,General Medicine,Ocean Engineering,General Medicine,General Medicine,General Medicine,General Medicine,General Earth and Planetary Sciences,General Environmental Science,General Medicine
Reference14 articles.
1. Kozhinova TA. Formation and course of alcoholism in men with various character accentuations according to inpatient examination data. Dissertation for the degree of Doctor of Medical Sciences. M., 2019; 4 s. Russian.
2. Kirzhanova VV, Grigorova NI, Bobkov EN, Kirzhanov VN, Sidoryuk OV. Activities of drug treatment services in the Russian Federation in 2020–2021: Analytical review. 2022; 24 s. Russian.
3. Hart AB, Kranzler HR. Alcohol dependence genetics: lessons learned from genome-wide association studies (GWAS) and post-GWAS analyses. Alcohol Clin Exp Res. 2015; 39 (8)1312–1327. DOI: 10.1111/acer.12792
4. Kibitov AO. Genetic aspects of narcological diseases. Monograph. M., 2021; 312 s. Russian.
5. Hall FS, Drgonova J, Jain S, Uhl GR. Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? Pharmacol Ther. 2013; 140(3): 267–279. DOI: 10.1016/j.pharmthera.2013.07.006.